|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/28/18 China Health Inds Holdings, Inc. 10-K 6/30/18 71:3.8M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 547K
2: EX-21.1 List of Subsidiaries HTML 17K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 20K
12: R1 Document and Entity Information HTML 52K
13: R2 Consolidated Balance Sheets HTML 115K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 29K
15: R4 Consolidated Statements of Operations and HTML 119K
Comprehensive Income (Loss)
16: R5 Consolidated Statements of Stockholders' Equity HTML 42K
17: R6 Consolidated Statements of Cash Flows HTML 141K
18: R7 Organization and Business Background HTML 37K
19: R8 Significant Accounting Policies HTML 79K
20: R9 Assets Sale HTML 26K
21: R10 Short Term Investments HTML 23K
22: R11 Accounts Receivable HTML 21K
23: R12 Inventories HTML 25K
24: R13 Construction in Progress HTML 24K
25: R14 Property, Plants and Equipment HTML 27K
26: R15 Intangible Assets HTML 26K
27: R16 Short-Term Loan HTML 23K
28: R17 Related Party Debts HTML 24K
29: R18 Income Taxes HTML 49K
30: R19 Earnings Per Share HTML 30K
31: R20 Commitments and Contingencies HTML 24K
32: R21 Major Suppliers and Customers HTML 24K
33: R22 Segment Reporting HTML 66K
34: R23 Subsequent Events HTML 21K
35: R24 Significant Accounting Policies (Policies) HTML 159K
36: R25 Significant Accounting Policies (Tables) HTML 21K
37: R26 Inventories (Tables) HTML 26K
38: R27 Construction in Progress (Tables) HTML 23K
39: R28 Property, Plants and Equipment (Tables) HTML 25K
40: R29 Intangible Assets (Tables) HTML 25K
41: R30 Related Party Debts (Tables) HTML 23K
42: R31 Income Taxes (Tables) HTML 43K
43: R32 Earnings Per Share (Tables) HTML 28K
44: R33 Segment Reporting (Tables) HTML 66K
45: R34 Organization and Business Background (Details) HTML 81K
46: R35 Significant Accounting Policies (Details) HTML 30K
47: R36 Significant Accounting Policies (Details Textual) HTML 46K
48: R37 Assets Sale (Details) HTML 35K
49: R38 Short Term Investments (Details) HTML 23K
50: R39 Accounts Receivable (Details) HTML 25K
51: R40 Inventories (Details) HTML 31K
52: R41 Inventories (Details Textual) HTML 21K
53: R42 Construction in Progress (Details) HTML 23K
54: R43 Construction in Progress (Details Textual) HTML 26K
55: R44 Property, Plants and Equipment (Details) HTML 36K
56: R45 Property, Plants and Equipment (Details Textual) HTML 25K
57: R46 Intangible Assets (Details) HTML 36K
58: R47 Intangible Assets (Details Textual) HTML 27K
59: R48 Short-Term Loan (Details) HTML 37K
60: R49 Related Party Debts (Details) HTML 26K
61: R50 Income Taxes (Details) HTML 33K
62: R51 Income Taxes (Details 1) HTML 42K
63: R52 Income Taxes (Details 2) HTML 43K
64: R53 Income Taxes (Details 3) HTML 30K
65: R54 Income Taxes (Details Textual) HTML 39K
66: R55 Earnings Per Share (Details) HTML 43K
67: R56 Major Suppliers and Customers (Details) HTML 45K
68: R57 Segment Reporting (Details) HTML 63K
70: XML IDEA XML File -- Filing Summary XML 125K
69: EXCEL IDEA Workbook of Financial Reports XLSX 80K
6: EX-101.INS XBRL Instance -- chhe-20180630 XML 897K
8: EX-101.CAL XBRL Calculations -- chhe-20180630_cal XML 178K
9: EX-101.DEF XBRL Definitions -- chhe-20180630_def XML 310K
10: EX-101.LAB XBRL Labels -- chhe-20180630_lab XML 761K
11: EX-101.PRE XBRL Presentations -- chhe-20180630_pre XML 590K
7: EX-101.SCH XBRL Schema -- chhe-20180630 XSD 140K
71: ZIP XBRL Zipped Folder -- 0001213900-18-013171-xbrl Zip 109K
Exhibit 31.2
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Xin Sun, certify that:
1. I have reviewed this Form 10-K of China Health Industries Holdings, Inc.;
2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
| a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; | |
| b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; |
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
| a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting. |
| Date: September 28, 2018 | /s/ Xin Sun |
| Xin Sun | |
| Chief Financial Officer (principal financial officer and principal accounting officer) |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/28/18 | None on these Dates | ||
| For Period end: | 6/30/18 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/13/23 China Health Inds Holdings, Inc. 10-K 6/30/23 72:5M EdgarAgents LLC/FA 4/10/23 China Health Inds Holdings, Inc. 10-K/A 6/30/22 69:4.7M EdgarAgents LLC/FA 2/24/23 China Health Inds Holdings, Inc. 10-K/A 6/30/22 69:4.7M EdgarAgents LLC/FA 9/15/22 China Health Inds Holdings, Inc. 10-K 6/30/22 71:4.7M EdgarAgents LLC/FA 9/20/21 China Health Inds Holdings, Inc. 10-K 6/30/21 69:4.4M EdgarAgents LLC/FA 10/13/20 China Health Inds Holdings, Inc. 10-K 6/30/20 68:3.6M EdgarAgents LLC/FA |